LOS ANGELES -- The HOPE trial made another case for extending the therapeutic window for IV thrombolysis in acute ischemic stroke, potentially widening the pool of people eligible for therapy. Among ...
Stroke poses a major threat to public health, and this threat is predicted to worsen in the years to come. Simcere is a company dedicated to creating novel therapeutic solutions to meet this urgent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback